High Point Bank & Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$58K Hold
400
0.02% 210
2016
Q3
$50K Hold
400
0.01% 231
2016
Q2
$53K Hold
400
0.01% 220
2016
Q1
$56K Hold
400
0.01% 216
2015
Q4
$56K Sell
400
-200
-33% -$27.6K 0.01% 219
2015
Q3
$84K Hold
600
0.02% 203
2015
Q2
$99K Hold
600
0.03% 194
2015
Q1
$93K Hold
600
0.03% 200
2014
Q4
$75K Hold
600
0.03% 212
2014
Q3
$72K Hold
600
0.02% 207
2014
Q2
$65K Hold
600
0.02% 220
2014
Q1
$60K Hold
600
0.02% 226
2013
Q4
$55K Hold
600
0.02% 227
2013
Q3
$50K Hold
600
0.02% 239
2013
Q2
$49K Buy
+600
New +$44.9K 0.02% 238

Other funds holding ELV

High Point Bank & Trust's ELV Position: Q4 2016 in Review

High Point Bank & Trust held its Elevance Health (ELV) position steady in Q4 2016 at 400 shares worth $58K. The position accounts for 0.02% of the portfolio, ranked #210.

High Point Bank & Trust first reported a position in ELV in Q2 2013 and has held it in 15 quarters since. The position peaked at $99K in Q2 2015. 783 funds tracked by Wall St. Rank hold ELV as of Q4 2016.

  • High Point Bank & Trust held 400 shares of Elevance Health worth $58K as of Q4 2016.
  • High Point Bank & Trust left its Elevance Health share count unchanged in Q4 2016.
  • Elevance Health made up 0.02% of High Point Bank & Trust's portfolio in Q4 2016, its #210 holding.
  • High Point Bank & Trust first reported a position in Elevance Health in Q2 2013 and has held it in 15 quarters since.
  • High Point Bank & Trust's Elevance Health position peaked at $99K in Q2 2015.
  • 783 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.